Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.
Shares of Edwards Lifesciences (NYSE:EW) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $103.44.